Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corneal Uptake of Riboflavin Eye Drops
NCT04062435Completed
- Sponsor
- Luzerner Kantonsspital
- Start
- Dec 2019
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of riboflavin in keratoconus (2 arms), sponsored by Luzerner Kantonsspital. Primary endpoint: Quantitative changes in anterior chamber riboflavin concentrations at 3 hours. Started Dec 2019; status: completed.
02
Drugs
riboflavin
03
Conditions
keratoconus
Beyond the preview
Go deeper on NCT04062435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04062435.